| 三维适形放射治疗 | 3D- CRT 3dimensional comformal radiation therapy |
| 主动呼吸控制技术 | ABC active breath control |
| 自体骨髓移植 | ABMT autologous bone marrow transplantation |
| 加速分割 | AF accelerated fractionation |
| 加速超分割 | AHF accelerated hyperfractionation |
| 适应性照射 | ART adaptive radiotherapy |
| 毛细血管扩张性共济失调 | AT Ataxia Talangiectasia |
| 基准剂量 | BD basal dose |
| 生物等效剂量 | BED biologically effective dose |
| 射束方向视图 | BEV beam eye view |
| 身体质量指数 | BMI body mass index |
| 血氧水平依赖法 | BOLD blood-oxygen-level-dependent |
| 生物反应调节剂 | BRMs biological response modifiers |
| 生物靶区 | BTV biological target volume |
| 同时小野加量加速超分割放疗 | CBHART concomitant boost hyperfractionated accelerated radiation therapy |
| 儿童癌症研究组织 | CCG Children’s Cancer Group |
| 细胞周期依赖性蛋白激酶 | CDK cyclin-dependent kinase |
| 常规分割 | CF conventional fractionation |
| 连续加速超分割放疗 | CHART continuous hyperfractionated accelerated radiation therapy |
| 靶区覆盖指数 | CI coverage index |
| 宫颈上皮内瘤变 | CIN cerbical intraepithelial neoplasia |
| 抵剂量率持续照射 | CLDR continuous low dose rate radiotherapy |
| 皮肤恶性淋巴瘤 | CML cutaneous malignant lymphoma |
| 床角预览视图 | CPV coach’s preview |
| 计算机体层显影 | CT computed tomography |
| 临床靶区 | CTV clinical target volume |
| 原发灶不明的转移癌 | CUP carcinoma of unknown primary |
| 真皮内树突状细胞 | DDCs dermal dendritic cells |
| 无瘤生存 | DFS disease free survival |
| 剂量修饰因子 | DMF dose modifying factor |
| 蛋白质交联 | DPC DNA protein cross-linking DNA- |
| 剂量减少系数 | DRF dose reduction factor |
| 数字重建图像 | DRR digitally reconstructed radiography |
| 数字减影血管造影 | DSA digital subtractive angiography |
| 双链断裂 | DSB double strand break |
| 剂量-体积直方图 | DVH dose volume histograms |
| 电子反向散射因子 | EBF electron backscatter factor |
| 细胞外基质 | ECM extracellular matrix |
| 表皮生长因子受体 | EGFR epithelial growth factor receptor |
| 逐步递量加速超分割放疗 | EHART escalating hyperfractionated accelerated radiation gherapy |
| 靶外体积指数 | EI external volume index |
| 电子射野影像系统 | EPID electronic portal imaging device |
| 等效均一剂量 | EUD dffective uniform dose |
| 氟代脱氧葡萄糖 | 18F-FDG 18F-fluorodeoxyglucose |
| 滤泡中心性淋巴瘤 | FCCL follicular center cell lymphoma |
| 分次剂量因子 | FDF fractionation-dosage factor |
| 高剂量率分次近距离治疗 | FHDR fractionated high dose rate brachytherapy |
| 纤维板层样肝细胞肝癌 | FL-HCC fibrolamellar hepatocellular carcinoma |
| 局灶性结节增生 | FNH focal nodular hyperplasia |
| 分次立体定向放射治疗 | FSRT fractionated stereotactic radiotherapy |
| 功能亚单元 | FSU functional subunits |
| 生殖细胞瘤 | GCT germ cell tumor |
| 肿瘤靶区或肉眼靶区 | GTV gross tumor volume |
| 肝细胞腺瘤 | HA hepatocellular adenoma |
| 热疗加化疗 | HC hyperthermia and chemotherapy |
| 肝细胞肝癌 | HCC hepatocellular carcinoma |
| 超剂量区 | HD hyperdose sleeve |
| 超分割 | HF hyperfractionation |
| 靶区剂量均匀性指数 | HI relative dose homogeneity index |
| 热疗加放疗 | HR hyperthermia and radiation |
| 热疗加放化疗 | HRC hyperthermia and radiochemotherapy |
| 半价层 | HVL half value layer |
| 免疫细胞瘤 | IC immunocytoma |
| 间隔细胞减灭术 | ICR interval cytoreductive or intervening cytoreduction |
| 国际辐射单位与测量委员会 | ICRU International Commission on Radiation units and Measurements |
| 影像学引导的适应性照射 | IGART image guided adaptive radiotherapy |
| 影像学引导的放射治疗 | IGRT image guided radiotherapy |
| 内边界 | IM internal margin |
| 弧形调强技术 | IMAT intensity modulated arc therapy |
| 调强放射治疗 | IMRT intensity modulated radiation therapy |
| 全盆调强放射治疗 | IM-WPRT intensity-modulated whole pelvic radiotherapy |
| 免疫增值性小肠病 | IPSID immunoproliferative small intestinal disease |
| 国际标准化组织 | ISO international Organization for Standardization |
| 内靶区 | ITV internal target volume |
| 照射靶区 | IV irradiation volume |
| 表皮胶原细胞 | KCs keratinocytes |
| 后程加速超分割放疗 | LCHART late-course hyperfractionated accelerated radiation therapy |
| 朗罕氏细胞 | LCs Langerhans cells |
| 致死损伤 | LD lethal damage |
| 正常晚反应组织 | LENT late effective normal tissues |
| 线性能量传递 | LET linear energy transfer |
| 局部加温 | LH local hyperthermia |
| 标记指数 | LI labeling index |
| 线性最小二乘法 | LLS linear least squares |
| 模型或线性二次模型 | LQ linear quadratic model LQ |
| 平均中心剂量 | MCD mean central dose |
| 多叶调强补偿器 | MIMiC multivaane intensity modulation compensator |
| 多叶准直器 | MLC multileaf collimator |
| 磁共振成像 | MRI magnetic resonance imaging |
| 最小靶剂量 | MTD minimum target dose |
| 温和加温 | MTH mild temperature hyperthermia |
| 机器跳数 | MU monitor unit |
| 美国综合癌症工作者 | NCCN National Comprehensive Cancer Network |
| 无疾病证据 | NED no evidence of disease |
| 神经纤维瘤病 | NF neurofibromatosis |
| 非霍奇金淋巴瘤 | NHL non-Hodgkin Lymphoma |
| 非小细胞肺癌 | NSCLC non-small cell lung cancer |
| 名义标准剂量 | NSD nominal standard dose |
| 非精原细胞性生殖细胞瘤 | NSGCT nonseminomatous germ cell tumor |
| 正常组织并发症概率 | NTCP normal tissue complication probability |
| 离轴比 | OAR off axial ratio |
| 敏感器官 | OAR organ at risk |
| 氧增强比 | OER oxygen enhancement ratio |
| 超剂量体积指数 | OI overdose volume index |
| 隐匿原发灶 | OPM ocult primary malignancy |
| 射野输出因子 | OUF output factor |
| 预防性全脑照射 | PCI propylactic cranial irradiation |
| 原发性皮肤恶性淋巴瘤 | PCML primary cutaneous malignant lymphoma |
| 百分深度剂量 | PDD percentage depth dose |
| 脉冲剂量率近距离治疗 | PDRR pulsed dose rate brachytherapy |
| 正电子发射断层扫描 | PET positron emission tomography |
| 防护系数 | PF protection factor |
| 潜在致死损伤 | PLD potential lethal damage |
| 外周淋巴结地址素 | PNAd peripheral node addressin |
| 原始神经外胚层肿瘤 | PNETs primitive neuroectodermal tumor |
| 胰腺癌胚抗原 | POA pancreatic oncofetal antigen |
| 前列腺特异抗原 | PSA prostate specific antigen |
| 精确放疗 | PT precision radiotherapy |
| 经皮腔内冠状动脉成型术 | PTCA percutaneous transluminal coronary angioplasty |
| 计划靶区 | PTV planning target volume |
| 无并发症控制概率 | PUC probability of uncomplicated control |
| 多不饱和脂肪酸 | PUFA polyunsaturated fatty acid |
| 质量保证／质量控制 | QA/QC quality assurance/quality control |
| 生活质量 | QOL quality of life |
| 二次规划法 | QP quadratic programming |
| 相对生物效应 | RBE relative biological effectiveness |
| 参考剂量 | RD reference dose |
| 治疗室内视图 | REV room＇s eye view |
| 区域加温 | RH regional hyperthermia |
| 源轴距 | SAD source axis distance |
| 皮肤相关淋巴样组织 | SALT skin associated lymphoid tissue |
| 散射空气比 | SAR scatter air ratio |
| 分段加速超分割放疗 | SCHART split-course hyperfractionated accelerated radiation therapy |
| 小细胞肺癌 | SCLC small cell lung cancer |
| 增敏比 | SER sensitization enhancement ratio |
| 加权综合指数 | SI sum index |
| 大野照射及小野追加剂量照射 | SIB simultaneously integrated boosting |
| 国际儿童肿瘤研究组织 | SIOP International Society for Paediatric Oncology |
| 皮肤免疫系统 | SIS skin immune system |
| 亚致死损伤 | SLD sublethal damage |
| 哨位淋巴结 | SLN sentinel lymph node |
| 哨位淋巴结活检技术 | SLNB sentinel lymph node biopsy |
| 摆位边界 | SM set-up margin |
| 散射最大剂量比 | SMR scatter maximum ratio |
| 扩展布拉格峰 | SOBP spread out Bragg peak |
| 单光子发射型计算机扫描 | SPECT single photo emmision computerized tomography |
| 散射体模比 | SPR scatter phantom ratio |
| 立体定向放射外科 | SRS stereotactic radiosurgery |
| 立体定向放射治疗 | SRT stereotactic radiation therapy |
| 单链断裂 | SSB single strand break |
| 源皮距 | SSD source skin distance |
| 源瘤距 | STD source tumor distance |
| 上腔静脉综合征 | SVCS superior vena cave syndrome |
| 奇异值分解法 | SVD singular value decomposition |
| 肿瘤相关抗原 | TAA tumor associated antigen |
| 经导管动脉栓塞术 | TAE transcatheter arterial embolization |
| 组织空气比 | TAR tissue air ratio |
| 肿瘤控制剂量 | TCD tumor control dose |
| 肿瘤控制概率 | TCP tumor control probability |
| 热增强比 | TER thermal enhancement ratio |
| 治疗增益系数（因子） | TGF therapeutic gain factor |
| 热释光剂量计 | TLD thermoluminescence dosimeters |
| 组织最大剂量比 | TMR tissue maximum ratio |
| 潜在倍增时间 | Tpot potertial doubling time |
| 组织体模比 | TPR tissue phantom ratio |
| 治疗计划系统 | TPS treatment planning system |
| 治疗比 | TR therapeutic ratio |
| 电子线全身照射 | TSEI total skin electron irradiation |
| 治疗靶区 | TV treatment volume |
| 治疗体积比 | TVR treatment volume ratio |
| 程序外DNA合成 | UDS unscheduled DNA synthesis |
| 国际抗癌联盟 | UICC International Union Against Cancer |
| 血管内皮生长因子 | VEGF vascular endothelial growth factor |
| 全身加温 | WBH whole body huperthermia |